Monday, April 24, 2017

Fresenius nears deal to acquire Akorn

German healthcare conglomerate Fresenius is close to acquiring generic drugmaker Akorn in an all-cash deal valuing the company at more than $4 billion

from Mergers and Acquisitions http://ift.tt/2oYwQVF
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)